Answers are grounded in this paper and cite their sources.
T HIS paper is the second of a series of reports dealing with a long-term experience with radioactive phosphorus (P32) in the treatment of malignant lymphomas, leukemias, and related diseases.In a previous communication,4 a nine-year survey of the P32 treatment of lymphatic leukemia was reported.In this country, the rationale for the use of external total-body radiation and selective local radiation by roentgen rays for the treatment of lymphomas and leukemias was established early in this century by Pusey and Senn.With the advent. of the development and preparation of radioactive isotopes from cyclotrons and later from nuclear reactors of the U. S. Atomic Energy Commission, it became feasible to accomplish internal total-body radiation.It is important to emphasize that cure has not been effected by any form of radiation therapy, whether by external or internal means.Minot and his colleagues, however, were able to demonstrate in 1924 that, although the survival of patients with leukemic diseases was not prolonged significantly by means of therapeutic roentgen rays, definite palliation was achieved with this method of treatment.This report will delineate a ten-year (actually ten years, nine months, twenty-four days) experience at the Memorial Hospital in the palliative therapy of myeloid leukemia with P32.T h e study was begun on February 6, From the Medical Service of the Memorial Ceuter for Cancer and Allied Diseases, New York, New York.
No takes yet. Share an insight, caveat, or question.
Diamond et al. (1951) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: